CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
  • About
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

Analytics: Where Does it Stand in Life Sciences Industry

Analytics: Where Does it Stand in...

The Plant-Based Market is being Driven by Key Consumer Trends

The Plant-Based Market is being...

Why DNA Sequencing in Biotechnology is Critical

Why DNA Sequencing in Biotechnology...

Healthcare Packaging Lines: Tips for Improving Sustainability And Performance

Healthcare Packaging Lines: Tips for...

Predictive Analytics: 3 Ways it Can Boost Commercialization Efforts

Predictive Analytics: 3 Ways it Can...

Here's How Data Takes Part in Driving Effective R&D for Life Sciences

Here's How Data Takes Part in Driving...

Drug Discovery and Development: Toward a Brighter Future with Big Data

Drug Discovery and Development:...

Data Analytics and Data Science Platforms for Life Sciences

Data Analytics and Data Science...

Analytics: Where Does it Stand in Life Sciences Industry

Analytics: Where Does it Stand in...

The Plant-Based Market is being Driven by Key Consumer Trends

The Plant-Based Market is being...

Why DNA Sequencing in Biotechnology is Critical

Why DNA Sequencing in Biotechnology...

Healthcare Packaging Lines: Tips for Improving Sustainability And Performance

Healthcare Packaging Lines: Tips for...

Predictive Analytics: 3 Ways it Can Boost Commercialization Efforts

Predictive Analytics: 3 Ways it Can...

Here's How Data Takes Part in Driving Effective R&D for Life Sciences

Here's How Data Takes Part in Driving...

Drug Discovery and Development: Toward a Brighter Future with Big Data

Drug Discovery and Development:...

Data Analytics and Data Science Platforms for Life Sciences

Data Analytics and Data Science...

What You Should Know Aboutthe Human Genome

Life Sciences Review | Monday, May 31, 2021
Tweet

The clinical-genomics efforts concentrate on known genes because they are the fast and cost-efficient approach to genome analysis.


FREMONT, CA: The Human Genome Project's technology and resources are beginning to profoundly influence biomedical research and develop a wide range of biological research and clinical medicine. Researchers pursuing genes related to numerous genetic conditions, including myotonic dystrophy, fragile X syndrome, neurofibromatosis types 1 and 2, inherited colon cancer, Alzheimer's disease, and familial breast cancer, have benefited from increasingly detailed genome maps.


A new phase of molecular medicine is on the horizon, focusing on the root causes of disease rather than treating symptoms. Quick and more specific diagnostic tests will allow for earlier treatment of a wide range of ailments. Medical researchers can develop new therapeutic treatments based on new drug classes, immunotherapy techniques, avoidance of environmental factors that might trigger disease, and possible gene therapy augmentation or replacement of faulty genes.


Using the genome project's new abilities, DOE launched the Microbial Genome Program to process the genomes of bacteria helpful in energy production, environmental remediation, decreasing toxic waste, and industrial processing.


The Genomic Science Program (GSP) is a follow-up program that develops data and resources from the Human Genome Project, the Microbial Genome Program, and systems biology. GSP will accelerate the understanding of dynamic living systems to find solutions to DOE mission difficulties in energy and the environment.


Irrespective of the dependence on the inhabitants of the microbial world, researchers know significantly less about their number or nature. Less than 0.01 percent of every microbe has been cultivated and characterized, according to estimates. Microbial genome sequencing will help lay the groundwork for knowledge that will profit human health and the environment in the long run. More industrial applications of microbial abilities will boost the economy.


The knowledge gained from the characterization of complete microbial genomes will contribute to developing new energy-related biotechnologies like photosynthetic systems, microbial systems that perform in extreme environments, and organisms that can metabolize widely accessible renewable resources and waste material with great ease.


Advantages are also predicted to involve developing a wide range of new products, processes, and testing methods that will lay the groundwork for a cleaner environment. Nontoxic chemicals and enzymes will be used in biomanufacturing to decrease costs and enhance the efficiency of industrial processes. Microbial enzymes have been utilized to bleach paper pulp, stonewash denim, erase lipstick from glassware, break down the starch in brewing, and coagulate milk protein in cheese production. In medicine, microbial sequences may support researchers in the discovery of new human genes and highlight the pathogens' disease-causing properties.


Pharmaceutical researchers will also benefit from a comprehensive understanding of how pathogenic microbes end up causing disease. The sequencing of these microbes will aid in the discovery of weaknesses and the identification of new drug targets.


A better understanding of the microbial world will also offer insights into the techniques and restrictions of life on Earth. The data generated by this new program has assisted scientists in determining the minimum number of genes required for life and confirming the existence of a third major kingdom of life. New genetic techniques enable researchers to more clearly define the diversity of microorganisms and recognize those crucial to maintaining or rebuilding the function and integrity of large and small ecosystems. This information can also be used to track and predict environmental transformation. Finally, microbial community research provides models for comprehending biological interactions and evolutionary history.


See Also: Top Robotics Technology Companies


Weekly Brief

loading
> <
  • DNA Sequencing 2022

    Top Vendors

    Current Issue
  • BioTech Startups 2022

    Top Vendors

    Current Issue
  • DNA Sequencing 2022

    Top Vendors

    Current Issue
  • BioTech Startups 2022

    Top Vendors

    Current Issue

Read Also

Role of Predictive Genomics in Sustainable Healthcare

Role of Predictive Genomics in Sustainable Healthcare

A Conversational AI Approach to Regulatory Intelligence

A Conversational AI Approach to Regulatory Intelligence

A rise in DNA Sequencing Market is expected in coming years

A rise in DNA Sequencing Market is expected in coming years

Omniabio Inc. Announces Private Investor

Omniabio Inc. Announces Private Investor
Data analysis for next-generation sequencing worth USD1.2 billion by 2026 - Cloud-based platforms emerging as preferred solutions

Data analysis for next-generation sequencing worth USD1.2 billion by 2026 - Cloud-based platforms emerging as preferred solutions

Lithuania's Vision to Become a Biotech Hub in Europe

Lithuania's Vision to Become a Biotech Hub in Europe

Bridging the Diversity Gap in Genomics

Bridging the Diversity Gap in Genomics

How does Biotechnology Provide Solutions to Human Needs?

How does Biotechnology Provide Solutions to Human Needs?
Loading...

Copyright © 2022 Life Science Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/what-you-should-know-aboutthe-human-genome-nwid-380.html